ConceptioArchiveNCBI PubMed Central
NCBI PubMed Centralopen access

Less Is More: A Physiological Dose of Vitamin B12 Enhances Neural Recovery Compared to a High Dose in an H₂O₂-Stressed SH-SY5Y Neural-Like Cell Model.

Mathew AR et al. · ncbi_pmc
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
machine learning systems

Less Is More: A Physiological Dose of Vitamin B12 Enhances Neural Recovery Compared to a High Dose in an H₂O₂-Stressed SH-SY5Y Neural-Like Cell Model - PMC Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Search Log in Dashboard Publications Account settings Log out Search… Search NCBI Primary site navigation Search Logged in as: Dashboard Publications Account settings Log in Search PMC Full-Text Archive Search in PMC Journal List User Guide PERMALINK Copy As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Mol Neurobiol . 2026 Apr 17;63(1):569. doi: 10.1007/s12035-026-05841-9 Search in PMC Search in PubMed View in NLM Catalog Add to search Less Is More: A Physiological Dose of Vitamin B12 Enhances Neural Recovery Compared to a High Dose in an H₂O₂-Stressed SH-SY5Y Neural-Like Cell Model Aimee Rachel Mathew Aimee Rachel Mathew 1 Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy Find articles by Aimee Rachel Mathew 1 , Luca Buccini Luca Buccini 2 Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Rome, Italy 3 Research Centre for Nanotechnology for Engineering of Sapienza (CNIS), Sapienza University of Rome, Rome, Italy Find articles by Luca Buccini 2, 3 , Anacleto Proietti Anacleto Proietti 2 Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Rome, Italy 3 Research Centre for Nanotechnology for Engineering of Sapienza (CNIS), Sapienza University of Rome, Rome, Italy Find articles by Anacleto Proietti 2, 3 , Giacomo Di Matteo Giacomo Di Matteo 4 Department of Chemistry and Technology of Drugs, Sapienza University of Rome, Rome, Italy 5 NMR-Based Metabolomics Laboratory (NMLab), Sapienza University of Rome, Rome, Italy Find articles by Giacomo Di Matteo 4, 5 , Erisa Selita Erisa Selita 1 Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy Find articles by Erisa Selita 1 , Ilaria Serangeli Ilaria Serangeli 6 Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy Find articles by Ilaria Serangeli 6 , Roberta Stefanelli Roberta Stefanelli 7 Department of Psychology, Division of Neuroscience, Sapienza University of Rome, Rome, Italy Find articles by Roberta Stefanelli 7 , Elisa Gazzera Elisa Gazzera 1 Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy Find articles by Elisa Gazzera 1 , Francesco Mura Francesco Mura 2 Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Rome, Italy 3 Research Centre for Nanotechnology for Engineering of Sapienza (CNIS), Sapienza University of Rome, Rome, Italy Find articles by Francesco Mura 2, 3 , Luisa Mannina Luisa Mannina 4 Department of Chemistry and Technology of Drugs, Sapienza University of Rome, Rome, Italy 5 NMR-Based Metabolomics Laboratory (NMLab), Sapienza University of Rome, Rome, Italy Find articles by Luisa Mannina 4, 5 , Marco Rossi Marco Rossi 2 Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Rome, Italy 3 Research Centre for Nanotechnology for Engineering of Sapienza (CNIS), Sapienza University of Rome, Rome, Italy Find articles by Marco Rossi 2, 3 , Antonella De Jaco Antonella De Jaco 1 Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy Find articles by Antonella De Jaco 1 , Elena Miranda Elena Miranda 1 Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy Find articles by Elena Miranda 1 , Ada Maria Tata Ada Maria Tata 1 Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy Find articles by Ada Maria Tata 1 , Livia Angeloni Livia Angeloni 2 Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Rome, Italy 3 Research Centre for Nanotechnology for Engineering of Sapienza (CNIS), Sapienza University of Rome, Rome, Italy Find articles by Livia Angeloni 2, 3 , Piergiorgio La Rosa Piergiorgio La Rosa 8 Department of Neuroscience, Section of Human Anatomy, Catholic University of the Sacred Heart, Rome, Italy Find articles by Piergiorgio La Rosa 8 , Daniele Passeri Daniele Passeri 2 Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Rome, Italy 3 Research Centre for Nanotechnology for Engineering of Sapienza (CNIS), Sapienza University of Rome, Rome, Italy Find articles by Daniele Passeri 2, 3 , Virve Cavallucci Virve Cavallucci 6 Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy 9 Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy Find articles by Virve Cavallucci 6, 9, # , Marco Fidaleo Marco Fidaleo 1 Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy 3 Research Centre for Nanotechnology for Engineering of Sapienza (CNIS), Sapienza University of Rome, Rome, Italy Find articles by Marco Fidaleo 1, 3, ✉, # Author information Article notes Copyright and License information 1 Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy 2 Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Rome, Italy 3 Research Centre for Nanotechnology for Engineering of Sapienza (CNIS), Sapienza University of Rome, Rome, Italy 4 Department of Chemistry and Technology of Drugs, Sapienza University of Rome, Rome, Italy 5 NMR-Based Metabolomics Laboratory (NMLab), Sapienza University of Rome, Rome, Italy 6 Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy 7 Department of Psychology, Division of Neuroscience, Sapienza University of Rome, Rome, Italy 8 Department of Neuroscience, Section of Human Anatomy, Catholic University of the Sacred Heart, Rome, Italy 9 Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy ✉ Corresponding author. # Contributed equally. Received 2025 Aug 26; Accepted 2026 Mar 27; Issue date 2026. © The Author(s) 2026 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . PMC Copyright notice PMCID: PMC13090186  PMID: 41996029 Abstract Vitamin B12 (VitB12) plays a crucial role in neural homeostasis, and a high dose is preferred as treatment to support recovery from neural impairments. However, a significant knowledge gap remains regarding its dose-dependent effects, particularly in its influence on cellular recovery following neural damage. To address this, we utilized retinoic acid-differentiated SH-SY5Y cells, as an in vitro neural model, where we induced neural damage using hydrogen peroxide (H 2 O 2 ), followed by recovery in either a physiological or high dose of VitB12. Our findings reveal that a physiological dose of VitB12 promotes more efficient recovery by enhancing cell survival and promoting neurite elongation after H 2 O 2 insult, compared to a high dose. Recovery with a physiological dose of VitB12 was associated with an early-stage (2 h) activation of antioxidant defenses, suggesting a quicker cellular response to oxidative stress than the high dose. At later stages (24 h), recovery with a physiological dose of VitB12 enhances mitochondrial metabolic activity and morphodynamics, alongside promoting lipid remodeling and increased formation of lipid droplets (LDs). These lipid-related processes may collectively contribute to mitigating oxidative damage and reinforcing cellular resilience during recovery. Overall, our study highlights that a physiological dose of VitB12 not only activates antioxidant defenses earlier than the high dose but also induces later-stage lipid remodeling, potentially supporting neural recovery and homeostasis. Graphical Abstract Supplementary Information The online version contains supplementary material available at 10.1007/s12035-026-05841-9. Keywords: Vitamin B12, Oxidative damage, Neural recovery, Mitochondrial activity, Lipid remodeling, Neurite outgrowth, SH-SY5Y model Introduction Vitamin B12 (VitB12) has been recognized, since the 1960 s, as an indispensable cofactor in vital metabolic pathways and essential for maintaining cellular homeostasis. The detrimental effects of VitB12 deficiency have been extensively studied, demonstrating its contribution to multi-organ damage, including impaired nervous system function [ 1 – 4 ]. Epidemiologically, determining the exact prevalence of VitB12 deficiency is difficult due to multiple factors. In older adults, age-related organ dysfunction leads to deficiency rates between 1.2 and 40%, varying with living conditions, illness, and nutritional status [ 5 – 9 ]. Recent studies have highlighted a potential role of VitB12 in promoting neural recovery processes, following injury or impairment. For instance, VitB12 has been shown to enhance dendritic branching, improve synaptic plasticity, and boost memory performance in elderly mice [ 10 ]. It has also been found to counteract neuronal damage caused by endoplasmic reticulum (ER) stress and support the repair of injured nerve tissue [ 11 ]. Furthermore, VitB12 supplementation has demonstrated the ability to reverse the decline in dendritic complexity and spine density associated with traumatic brain injury (TBI), leading to improved synaptic plasticity, increased neuronal survival, and the restoration of cognitive functions [ 12 ]. In vitro experiments on SH-SY5Y cells, a widely used model for neural-like behavior studies, have likewise demonstrated the neuroprotective effects of VitB12 against H 2 O 2 -induced neuronal damage, mediated through both transcriptomic modulation [ 13 ] and lipidomic modification [ 14 ]. Collectively, the results of the mentioned studies suggest a potentially critical role for VitB12 in facilitating neuronal recovery after damage. Although these studies directly address the role of VitB12 in neural repair, significant gaps remain in our understanding of the precise biological mechanisms involved. At the biochemical level, VitB12 plays a crucial role in both cytoplasmic and mitochondrial metabolic pathways. It is involved in the remethylation of homocysteine to methionine via methionine synthase (MTR) [ 1 – 4 ] and in the conversion of L-methylmalonyl-CoA to succinyl-CoA through L-methylmalonyl-CoA mutase (MUT) [ 1 , 3 ]. Consequently, researchers have sought to link neurological dysfunctions with metabolic disturbances. However, recent studies have revealed that the consequences of VitB12 deficiency extend beyond the accumulation of toxic intermediates or substrate deficiencies (metabolic decompensation). They also include more profound cellular alterations, including molecular and structural changes at both the cellular and tissue levels (reviewed in [ 15 ]). High-dose VitB12 therapy is the preferred treatment approach, as it is generally considered non-toxic, with a low risk of severe adverse effects even with prolonged administration (reviewed in [ 16 ]). Nonetheless, dermatological reactions have been reported in some cases [ 17 ]. Although high-dose VitB12 is widely used and demonstrates therapeutic efficacy, a review of studies on VitB12 treatment highlights a significant challenge in determining the optimal dosage for achieving maximum therapeutic benefit [ 15 ]. To clarify the potential role of VitB12 dosage in neuroprotection and explore its underlying mechanisms, we present a study investigating dose-dependent effects in SH-SY5Y neuronal cells exposed to oxidative stress induced by hydrogen peroxide (H 2 O 2 ), a model that simulates neuronal damage [ 18 , 19 ]. The results of this in vitro study showed that supplementation with a physiological dose of VitB12 significantly improved cell survival, promoted neural outgrowth, and rapidly upregulated genes linked to antioxidant defense within a few hours, providing a faster and more efficient response to H 2 O 2 -induced injury compared to the higher dose. Furthermore, the enhancement of mitochondrial network fusion, the relative enrichment of unsaturated lipids, and the increased formation of lipid droplets (LDs) observed at later time points may represent a delayed protective mechanism that is not evident with the higher dose. Overall, these findings suggest that a physiological dose of VitB12 is more effective in promoting cellular recovery from H 2 O 2 -induced damage. Materials and Methods Cell Culture Human neuroblastoma cell line SH-SY5Y were cultured in flasks and dishes and maintained in MEM (Aurogene) supplemented with 10% FBS (Sigma-Aldrich), 1% streptomycin (Cytiva), 50 IU/mL penicillin (Cytiva), 1% L-glutamine (Cytiva), 1% amphotericin (Cytiva), and 0.2% normocin (InvivoGen) in a humidified atmosphere of 5% CO 2 in air at 37 °C inside an incubator. The medium for cell culture was replaced every 3 days, and the cells were subcultured on reaching 85–95% confluency. The number of cell passages was always maintained between 2 and 15. All cell culture techniques were performed inside a laminar air flow chamber hood under sterile conditions. SH-SY5Y Differentiation and Treatments For differentiation/treatment experiments, cells were seeded at a density of 8.33 × 10 4 cells per cm 2 , and for microscopic images and staining experiments, cells were seeded at a density of 4.16 × 10 4 cells per cm 2 . The seeding was performed 1 day prior to the start of differentiation/treatment experiments. After 24 h of cell seeding, differentiation was induced by decreasing the amount of FBS in the culture medium, followed by adding retinoic acid (RA). RA stock was prepared by dissolving 3 mg of RA powder (Sigma-Aldrich) in 1 mL in absolute ethanol, such that the concentration of the stock is 10 mM. Since RA is extremely light-sensitive, precautions were taken while adding it into the medium in the absence of light. The differentiation was terminated by removing the differentiation media after 3 days (72 h). At the end of 3 days, for oxidatively insulting the differentiated SH-SY5Y cells, an H 2 O 2 stock of 10 mM was prepared by dissolving 30% H 2 O 2 (Sigma-Aldrich) solution in ultrapure water. This was further diluted in the MEM medium (with 0% FBS) to prepare the final concentration, and the cells were incubated for 30 min at 37 °C inside an incubator for inducing oxidative stress. It should be ensured that the cells were devoid of any traces of FBS, by rinsing the wells with 1× phosphate-buffered saline (PBS) (Aurogene). For evaluating the role of VitB12 in the neural recovery from the damage induced by the oxidative stress, a stock of 20 mM VitB12 (Sigma-Aldrich) was dissolved in injectable water, followed by dissolving the stock in MEM containing 1% FBS to prepare the final concentration with the physiological and a high dose of VitB12. Because cobalamins are photolabile, VitB12 stock and working solutions were handled under reduced-light conditions and prepared from fresh or single-use aliquots to minimize photodegradation. VitB12-supplemented recovery media were prepared immediately before use. This medium was later added to the cells, and the plates were incubated at 37 °C inside an incubator for neural recovery. It should be ensured that the cells were devoid of any traces of H 2 O 2 before adding the media containing VitB12, by rinsing the wells with 1× PBS. Furthermore, the images of the differentiated cells under different conditions were captured using CamLabLite camera and software (Bresser MikroCam, Informer Technologies, Inc.) and the average number of neurites per cell and the mean neurite outgrowth length per cell were quantified using the NeuroJ plugin developed for the ImageJ software [ 20 ]. Cell Counting and Erythrosin B–Stained Positive Assay For cell counting experiments, cells were seeded at a density of 8.33 × 10 4 cells per cm 2 , 1 day prior to the start of the experiment. Cell counting experiments were performed to investigate the optimum differentiation protocol and optimum concentration of H 2 O 2 and to identify the extent of cell growth and cell death induced by various treatments with H 2 O 2 and/or VitB12. After 24 h of cell seeding, differentiation was induced in the SH-SY5Y cells, followed by several treatments with H 2 O 2 and/or VitB12. After the respective treatments, the media were collected from all the wells, and the wells were washed with 1× PBS, which were also collected. This step was performed in order to collect all the dead cells that were detached and floating in the medium. The live cells in the wells were trypsinized gently using 1× trypsin (Cytiva) and were collected in the same centrifuge tubes, followed by centrifugation at 6000 rpm at 4 °C for 5 min. The cell pellets were resuspended in 1× PBS, and the live and dead cell numbers were obtained from LunaFX7 Automated Cell Counter (Logos Biosystems) using the erythrosin B staining (Logos Biosystems) method by mixing cell suspension and trypan blue in the ratio 1:1. Western Blot For western blot analysis, the cells were seeded at a density of 8.33 × 10 4 cells per cm 2 . The relative expression of several mature neuronal markers, proteins, and a transcriptional factor was evaluated by western blot immunoassay. After the respective treatments, cells were washed with 1× PBS to remove excess of the culture medium. The cells were lysed directly with western blot sample buffer (6.25% 1 M Tris pH = 6.8, 2% sodium dodecyl sulfate, 10% glycerol, 0.01% bromophenol blue, and 5% β-mercaptoethanol, from Invitrogen/Gibco/Sigma-Aldrich, in distilled water) or lysed with NP-40 lysis buffer (1 M Tris-HCl pH = 8, 5 M NaCl, 10% NP-40 from Sigma-Aldrich in distilled water), added with phosphatase inhibitors—50 µM NaF, 1 µM Na3VO4, 1 µM PMSF, and protease inhibitor cocktail from Sigma-Aldrich—and the lysates were sonicated. Protein content of the extracts was quantified using Bradford assay (Thermo Scientific), and 30 µg of total protein extracts was then separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Based on the molecular weights of the proteins of interest to be assessed, the stacking gel and the resolving gel contained 4% and 8–14% of acrylamide (Sigma-Aldrich), respectively. The separated proteins were then electrotransferred onto a polyvinylidene fluoride (PVDF) membrane (Merck Life Science), previously activated in 20% methanol (Fisher Scientific). The membrane was then incubated for 1 h at room temperature in 5% non-fat dry milk (PanReac AppliChem-ITW Reagents) and 0.2% Tween-20 (Fisher Scientific) in Tris-buffered saline (TBST) for blocking the non-specific bindings. After the blocking step, the membranes were washed with 1× TBST and probed with the primary antibodies in 5% non-fat dry milk or 3% bovine serum albumin (BSA) (Sigma-Aldrich) and 0.05% sodium azide (Sigma-Aldrich) in TBST (to prevent bacterial growth) at 4 °C overnight. The primary antibodies included—proliferative cell nuclear antigen (PCNA) (Santa Cruz Biotechnology), synaptophysin (SYP) (Santa Cruz Biotechnology), growth associated protein-43 (GAP-43) (Santa Cruz Biotechnology), CD320 (AB clonal), caspase-3 (AB clonal), Poly(ADP-ribose) polymerase 1 (PARP1) (AB clonal), catalase (Abcam), and β-actin (Immunological Sciences), diluted as per the instructions from the manufacturer. After removing the primary antibodies and washing the membranes with 1× TBST, the membranes were incubated with the corresponding secondary antibodies (Fortis Life Sciences) (diluted as per the instructions from the manufacturer), which were conjugated with horseradish peroxidase, at room temperature for 1 h. After removing the secondary antibodies, the membranes were washed with 1× TBST, and the bands were visualized by enhanced chemiluminescence assay (HyGLO, Denville Scientific Inc.) using ChemiDoc XRS + (BIO-RAD) and Image Lab software (BIO-RAD). RNA Extraction and qPCR Total RNA was isolated utilizing the Total RNA Purification Plus Kit (Norgen Biotek Corp.) in accordance with the manufacturer’s guidelines. Then, 1 µg of RNA was reverse-transcribed with a OneScript Plus cDNA Synthesis Kit (Abm), and cDNAs were amplified in qPCR experiments with 2× SensiFAST SYBR Lo-ROX Mix (Bioline) following the manufacturer’s instructions. The primer sequences used for gene amplification were as follows: for NRF2, the forward primer was 5′-CACATCCAGACAGACACCAGT and the reverse primer was 5′-GGGAATGTCTCTGCCAAAAGC; for GPX4, the forward primer was 5′-GGACGAGGGGAGGAGC and the reverse primer was 5′-ACGCGCACATGGTCCC; for NQO1, the forward primer was 5′-AGTTTGCTTACACTTACGCTGC and the reverse primer was 5′-CCCTTGCAGAGAGTACATGGAG; for SOD1, the forward primer was 5′-GGTGTGGCCGATGTGTCTAT and the reverse primer was 5′-CCTTTGCCCAAGTCATCTGC; for SOD2, the forward primer was 5′-GTTGGGGTTGGCTTGGTTTC and the reverse primer was 5′-TGCTCCCACACATCAATCCC; and for RPL34, the forward primer was 5′-CCAGCGTTTGACATACCGAC and the reverse primer was 5′-TGCTTTCCCAACCTTCTTGGT. Target gene expression was normalized to Ribosomal protein L34 (RPL34) and to the control group and reported as “Relative expression (RPL34; vs control).” Immunocytochemistry For immunocytochemistry, the cells were seeded onto glass cover slips of 10 mm diameter at a density of 4.16 × 10 4 cells per cm 2 . After the respective treatment, cells were washed with 1× PBS to remove the excess of the culture medium, followed by the fixation of cells in 4% formaldehyde (FA) (Thermo Scientific) at room temperature for 15 min. After discarding the FA and washing the cells with 1× PBS, 0.1% Triton X-100 was added to the cells for permeabilization. On permeabilization, the fixed cells were washed again with 1× PBS, and the non-specific binding sites were blocked by incubating the cells with 5% normal goat serum (NGS) (Sigma-Aldrich) (also with 0.1% Triton X-100 and 0.05% sodium azide to prevent bacterial growth) in 1× PBS for 1 h in a humid chamber. Following the blocking step, the cells were washed with 1× PBS and incubated with the primary antibody, GAP-43 (1:100 in 5% NGS) overnight in a humid chamber at 4 °C. After removing the primary antibodies and washing the cells with 1× PBS, the cells were incubated with the corresponding secondary antibodies, conjugated with fluorophores (1:500 in 0.5% NGS) at room temperature for 1 h. After removing the secondary antibodies, the fixed cells were washed with 1× PBS and were finally mounted (1% DAPI in the mounting solution) (Invitrogen). The cells were then visualized under fluorescent microscopy, and the images were captured using ApoTome.2 microscopy (Zeiss) with a 63×/1.40 oil objective and Zeiss ZEN 3.6 (blue edition) software. Z-stack series consisted of 0.25-µm slice intervals. NMR Analysis A combined extraction of both polar and lipophilic metabolites from cell tissues was performed by utilizing a methanol/chloroform/water solvents mixture as described by Beckonert and colleagues [ 21 ]. Eighty milligrams of cell pellet was weighed in a falcon tube and 320 µL of methanol and 68 µL of distilled water were added into the tube, followed by vortex homogenization. In total, 160 µL of chloroform and 160 µL of distilled water were then added to the mixture, followed by vortexing again. The samples were then placed in the fridge for 15 min at 4 °C and later centrifuged at 1000 g for 15 min at 4 °C. The upper methanol/water phase (with polar metabolites), well separated by protein and cellular debris, was collected and dried under nitrogen flow. In order to prepare the cell tissue samples for NMR analysis, the dried hydroalcoholic phase was solubilized in 750 µL of 100 mM phosphate buffer solution with 0.2 mM trimethylsilylpropanoic acid (TSP) and 2 mM sodium azide (NaN 3 ) as demonstrated by Petrella and colleagues [ 22 ]. NMR analysis was carried out on a Jeol JNM-ECZ 600R (JEOL Ltd., Tokyo, Japan) operating at a proton frequency of 600.17 MHz and equipped with a Jeol 5 mm FG/RO DIGITAL AUTOTUNE probe. 1 H NMR experiments were carried out using a Carr Purcell-Meiboom-Gill (CPMG) filter to reduce broad signals from proteins and lipids using the following parameters: 298 K, 256 scans, residual water signal suppression with a presaturation pulse, 2.0 s relaxation delay, 90 pulse of 8.3 µs, 32 K data points, 16 dummy scan, autogain, spin echo delay time of 0.400 ms, total echo time of 64 ms, loop number 160, and 9000-Hz spectral width. 1 H spectra were then referenced to methyl group signals of TSP ( δ H = 0.00 ppm) in D 2 O. The signal identification was based on literature data [ 15 , 22 , 23 ], standard addition, and 1H-1H TOtal Correlated SpectroscopY (TOCSY) experiment, a two-dimensional (2D) NMR technique, performed under experimental conditions previously reported [ 24 ]. Spectrum processing and signal integration were then carried out with JEOL Delta software (v5.3.1). The three biological replicates were extracted, and each was analyzed once by NMR. Relative metabolite quantification was performed by normalizing each metabolite amount to the sum of all metabolite amounts in each spectrum (total metabolite sum), and the resulting dataset was autoscaled prior to statistical analyses [ 25 ]. MitoTracker Staining and Mitochondrial Analysis For MitoTracker staining procedure, the cells were seeded onto glass cover slips of 10 mm diameter at a density of 4.16 × 10 4 cells per cm 2 . MitoTracker is a far red-fluorescent dye that stains the mitochondria by binding to the thiol-reactive chloromethyl groups in the mitochondrial membrane of live cells and its accumulation is dependent upon the mitochondrial membrane potential. This dye can be retained even after cell fixation, thereby making it possible to evaluate the different parameters regarding mitochondrial biology in live cells such as the shape of the mitochondria (large/round, rod, punctate and networks), mitochondrial footprint, branch length mean, and network branches mean [ 26 ]. The lyophilized MitoTracker (Invitrogen) was dissolved in dimethyl sulfoxide (Fisher Bioreagents) to prepare a 1-mM stock solution, which was then stored at −20 °C and away from light. This stock was then diluted to a working concentration of 10 µM by dissolving in the serum-free media, followed by directly adding it into the media (into each of the wells), such that a final concentration of 100 nM was achieved. The cells were then incubated with MitoTracker for 10 min without the presence of light. The media with the dye was aspirated, and the cells were washed with 1× PBS which was warmed to 37 °C, followed by the fixation of cells in 4% FA at room temperature for 15 min. After discarding the FA and washing the cells with 1× PBS, 0.1% Triton X-100 was added to the cells for permeabilization. On permeabilization, the fixed cells were washed again with 1× PBS and were finally mounted (1% DAPI in the mounting solution). The cells were then visualized under fluorescent ApoTome.2 microscopy (Zeiss) with a 63×/1.40 oil objective, and the images were captured using Zeiss ZEN 3.6 (blue edition) software. The red fluorescence from the MitoTracker was detected using a 540–552-nm excitation and 590–660-nm emission filter set. Z-stack series consisted of 0.25-µm slice intervals. Three independent biological replicates were performed. For each biological replicate, two technical replicates (two coverslips) were analyzed. From each coverslip, three non-overlapping fields were acquired, and three cells were randomly selected per field for quantification. The mitochondrial analysis was then performed using the plugin Mitochondrial Network Analysis (MiNA) of the ImageJ software [ 27 ]. EDS RA-differentiated SH-SY5Y cells were seeded on silicon-supported substrates suitable for EDS analysis. RA-differentiated SH-SY5Y cells were washed twice with PBS and incubated for 24 h in MEM 1% FBS or MEM 1% FBS supplemented with VitB12 (0.01 µM or 1 µM). Following treatment, cells were washed with PBS and fixed with 4% formaldehyde for 15 min at room temperature. Samples were then washed with PBS and finally rinsed with distilled water. Samples were analyzed using the Zeiss Auriga Scanning Electron Microscope (Zeiss, DE) equipped with the STEM module to detect intracellular cobalt (Co) as a proxy for intracellular cobalamin. Elemental maps were acquired and Co was quantified as cps/eV and as a relative atomic fraction (at.%) among detected elements (C, N, O, Na, Si). EDS analysis on the cells was performed using a very low accelerating voltage (2.5 keV) to minimize the contribution from the silicon substrate and maximize the X-ray signal originating from the cells, while still allowing detection of the Co Lα1 line (~ 0.77 keV). DCFDA Staining and Cytosolic ROS Image Analysis DCFDA staining was performed according to the manufacturer’s instructions. Briefly, the cells were seeded onto glass cover slips of 10 mm diameter at a density of 4.16 × 10 4 cells per cm 2 and subjected to the recovery protocol as described above. Cytosolic oxidant-dependent signal during early recovery (2 h) was assessed using 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA; Sigma). DCFDA was dissolved in DMSO to prepare a 10-mM stock solution, which was stored at − 20 °C and protected from light. The stock was diluted in PBS and added to the cells to reach a final concentration of 10 µM. Cells were incubated with DCFDA for 15 min at 37 °C in the dark. After incubation, the dye-containing PBS was aspirated, and cells were washed with PBS (37 °C) three times and immediately observed. Fluorescence images were acquired at 200× magnification using a Nikon Eclipse TE300 microscope under identical acquisition settings across conditions. DCFDA fluorescence was quantified in Fiji/ImageJ using an automated workflow based on global background subtraction (rolling-ball), cell-center detection by Gaussian blurring followed by Find Maxima, and measurement of the median fluorescence intensity within a fixed circular region of interest centered on each detected cell. The percentage of DCFDA-positive cells was computed using an internal, experiment-specific threshold derived from the H 2 O 2 condition and applied consistently to all conditions within the same replicate. JC-1 Staining and Mitochondrial Membrane Potential Analysis JC-1 staining was performed according to the manufacturer’s instructions. Briefly, the cells were seeded onto glass cover slips of 10 mm diameter at a density of 4.16 × 10 4 cells per cm 2 and subjected to the recovery protocol as described above. Mitochondrial membrane potential (ΔΨm) during early recovery (2 h) was assessed using the JC-1 dye (Cayman Chemical). JC-1 was dissolved in DMSO to prepare a 2 mM stock solution, stored at − 20 °C and protected from light, and diluted in PBS to obtain a final concentration of 2 µM. Cells were incubated with JC-1 for 15 min at 37 °C in the dark. The dye-containing PBS was then aspirated, and cells were washed with PBS (37 °C) three times and immediately observed. Images were acquired at 200× magnification using a Nikon Eclipse TE300 microscope with identical acquisition settings across conditions for both green and red channels. Images were analyzed in Fiji/ImageJ by measuring the median fluorescence intensity in the green and red channels within a fixed region of interest per cell. Mitochondrial membrane potential was reported as the red/green fluorescence ratio (R/G). Raman Analysis Raman analysis of SH-SY5Y cells was performed using the confocal inVia™ Raman spectrometer (Renishaw, UK) with a 100X short-distance objective and an excitation line at 532.1 nm. Spectral acquisition was obtained with an energy of 50 mW, an exposure time of 10 s and 3 accumulations for every cell on the spectral range of 1000–3100 cm −1 and in the spectral region 1000–1800 cm −1 , several peaks were identified. For each Raman map, at least 1000 individual points were acquired for 1-s exposure time and 2 accumulations [ 28 ]. Formaldehyde-fixed cells on coverslips were subjected to single-cell Raman spectroscopy. The Raman data were processed with several steps to ensure the accuracy and reliability of the results. Initially, the background signal from the glass slide was subtracted to remove any interference from the non-cellular components. Following this, all spectra were normalized to the highest peak intensity to correct for any intensity variations between the samples. This normalization process allows for better comparison across different samples and experimental conditions. The Raman spectra were then subjected to advanced smoothing using the Savitzky-Golay method, with an interval of 10 and a polynomial order of 3. This method effectively reduces noise while preserving the spectral features, especially the peaks of interest. Additionally, spike removal was applied, using a backward spike removal algorithm with a maximum pixel width of 5 to correct any isolated spikes that could distort the data. Finally, each spectrum was interpolated and resampled to ensure uniformity in data points, facilitating accurate peak identification. For each treatment group, the spectra were averaged, and the Raman shift was determined using the following parameters: a peak finding threshold of 2.5% of the visible spectrum’s ordinate, a search interval of 15, and a position tolerance of 0.40% (analysis conducted using Spectragryph software). The peak values derived from the averaged spectrum of each treatment were subsequently used to extract the full width at half maximum (FWHM) values (peak intensities) across all samples. The peaks were then aligned by rounding to the nearest integer. These values were used for further analysis. Oil Red O (ORO) Staining For ORO staining procedure, the cells were seeded onto glass cover slips of 10 mm diameter at a density of 4.16 × 10 4 cells per cm 2 . ORO is a fat-soluble dye used for staining neutral lipids, namely triglycerides and cholesterol esters, in biological samples that allow the visualization of LDs [ 29 ]. Firstly, the 0.5% ORO solution was prepared by dissolving ORO powder (Sigma-Aldrich) in 60% isopropanol (Merck & Co.) and was incubated for 24 h at room temperature, followed by filtering using a 0.22 µm filter (GVS Filter Technologies), the next day. The cells were first washed with 1× PBS for 5 min each to remove the media and were then fixed with 4% FA for 20 min. After fixation, the cells were washed thrice with 1× PBS for 10, 5, and 5 min, respectively. Prior to rinsing the cells, the 0.3% ORO solution was prepared by diluting the 0.5% ORO solution with distilled water, followed by incubating the 0.3% ORO solution for 10 min at room temperature, followed by filtering again using a 0.22-µm filter. The cells were then rinsed with freshly prepared 60% isopropanol, followed by incubating them with 250 μL of 0.3% ORO for 40 min. After the incubation, the ORO solution was aspirated completely, and the cells were rinsed with 60% isopropanol again. Finally, the cells were washed thrice with 1× PBS for 10, 5, and 5 min, respectively, followed by mounting the coverslips with 1% DAPI in the mounting solution. Results and Discussion Cell Model SH-SY5Y cells are widely used as an in vitro neural model to study neurodevelopment and regeneration, following traumatic injury [ 30 , 31 ]. Differentiation is a crucial process required to generate an SH-SY5Y cell population that exhibits morphological and functional characteristics similar to those of neurons [ 31 ]. In order to employ an in vitro neurite outgrowth assay for assessing the role of VitB12 on a neuron-like model during recovery, after genotoxic stress imposed by H 2 O 2 , we optimized a cellular system at first (Supplementary, Fig. 1S ). As shown in Fig. 1S , a 3-day RA protocol under our conditions reduces the proliferative marker PCNA and increases neuronal markers (e.g., SYP) and induces clear neurite outgrowth. Moreover, neurite length reaches a plateau at later differentiation times (6–9 days; Fig. 1S ), supporting our decision to use the 3-day window to preserve a measurable dynamic range in which treatment-dependent pro-neuronal versus anti-neuronal effects during recovery can still be detected. Experimental Model To assess the potential beneficial effects of VitB12 in aiding recovery after H 2 O 2 insult, we subjected RA-differentiated SH-SY5Y cells to MEM (non-insulted cells) or two different concentrations of H 2 O 2 (25 µM and 50 µM) for 30 min in MEM. Subsequently, we allowed the cells to recover in unsupplemented medium (MEM + 1% FBS) or media supplemented with VitB12 at concentrations of 0.01 µM (physiological dose) or 1 µM (high dose) for a duration of either 2 h or 24 h. Here, the term “physiological dose” refers to a low-nanomolar supplementation in the tissue/brain-relevant order of magnitude, rather than a serum-mimicking concentration. Human post-mortem brain cobalamin content has been reported at 50–60-ng/g wet tissue, corresponding to ~ 36.9–44.3 pmol/g (i.e., ~ 36.9–44.3 nM-equivalent, assuming 1 g ≈ 1 mL) [ 32 ]. Consistently, rodent brain VitB12 measurements are reported in the pg/mg (ng/g) wet-weight range; in the TCblR/CD320 knockout mouse study, median brain VitB12 concentrations were 112.42 pg/mg in controls versus 8.59 pg/mg in KO animals, corresponding to ~ 83.0 pmol/g (~ 83.0 nM-equivalent) versus ~ 6.34 pmol/g (~ 6.34 nM-equivalent), respectively [ 33 ]. We do not imply direct equivalence to brain pharmacokinetics or CSF exposure; the term is used to denote a low-dose, tissue-plausible regime to probe dose-dependent recovery responses in vitro. To support intracellular entry under our conditions, we performed EDS mapping of intracellular cobalt as a proxy for intracellular VitB12 [ 34 ]. Because intracellular cobalt is expected to be extremely low, the EDS spectrum shows a small Co Lα1 peak in the VitB12-treated sample (near the instrumental detection limit), whereas this peak is absent in unsupplemented cells. This supports the conclusion that VitB12-derived cobalt becomes detectable intracellularly upon vitamin treatment (Fig. 2S , Table 1S ). Note that the unsupplemented media does not contain any traces of VitB12, thus establishing this “basal condition” as VitB12 deprivation condition [ 15 ] (Experimental design, Fig. 1 A). Recovery duration was selected based on the expected temporal dynamics of the biological response. Specifically, we included an early recovery time point (2 h) to capture rapid stress-responsive transcriptional signaling and early functional redox/mitochondrial readouts, and a later time point (24 h) to quantify more stable recovery-related phenotypes that require time to develop, such as changes in cell survival, neurite-associated structural remodeling, mitochondrial network organization, and metabolic/lipid reprogramming. Accordingly, gene-expression analyses were performed at both 2 h and 24 h, whereas all other endpoints were assessed at 24 h unless otherwise stated. Fig. 1. Open in a new tab The physiological dose of vitamin B12 during recovery reduces erythrosin B–positive stained cell numbers and enhances neurite length. A A schematic diagram showing the experimental design including the treatments and recovery. B Plot for cell death in percentage for varying concentrations of H 2 O 2 and VitB12. The conditions correspond to: Sample 1, differentiated SH-SY5Y cells in MEM containing 1% FBS; Sample 2, differentiated SH-SY5Y cells treated with 25 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Sample 3, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Sample 4, differentiated SH-SY5Y cells in MEM containing 1% FBS and 1 μM VitB12; Sample 5, differentiated SH-SY5Y cells treated with 25 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 1 μM VitB12; Sample 6, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 1 μM VitB12; Sample 7, differentiated SH-SY5Y cells in MEM containing 1% FBS and 0.01 μM VitB12; Sample 8, differentiated SH-SY5Y cells treated with 25 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12; Sample 9, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12. C Plot for cell number normalized to control (Sample 1) for varying concentrations of H 2 O 2 and VitB12. The conditions correspond to the same as above. D Microscopic images of differentiated SH-SY5Y cells treated with 25 µM and 50 µM concentrations of H 2 O 2 , followed by recovery in unsupplemented and supplemented media with VitB12. Scale bar corresponds to a length of 50 µm. E The quantification of the neurite outgrowth processes (in µm) obtained for differentiated SH-SY5Y cells treated with 0 µM, 25 µM, and 50 µM concentration of H 2 O 2 , followed by recovery in unsupplemented and supplemented media with VitB12. The conditions correspond to the same as above. Data are from 9 biological replicates and presented as mean ± SD. Statistical significance was determined using one-way ANOVA test, followed by Tukey’s test which compared the means of two or more independent groups: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. For cell number, comparison with Sample 1 was performed by using one sample t -test Recovery with a Physiological Dose of VitB12 Reduces the Number of Erythrosin B–Stained Positive Cells and Enhances Neurite Length The H 2 O 2 insult induced a dose-dependent positive erythrosin B staining of the cells, suggesting an increase in cell death, irrespective of whether the cells were allowed to recover under unsupplemented conditions or with a high dose of VitB12 (1 µM) (Fig. 1 B). Correspondingly, the cell number was reduced under these conditions (Fig. 1 C). Interestingly, when cells recovered in the media supplemented with a physiological dose of VitB12 (0.01 µM VitB12), the impact of H 2 O 2 exposure on cell death was diminished (Fig. 1 B), which coincided with a higher number of cells compared to the other conditions (Fig. 1 C). No differences in the mentioned parameters were observed between the supplemented conditions and the unsupplemented condition in the absence of H 2 O 2 insult (Fig. 1 B, C). Regarding the neurite outgrowth, supplementation with the physiological or high doses of VitB12 did not alter the neurite length, compared to the unsupplemented medium (Fig. 1 D, E). Furthermore, a significant decrease in neurite length was observed for the cells treated with H 2 O 2 both at 25 µM and 50 µM, irrespective of the recovery media type. Interestingly, on comparing the neurites of cells treated with 50 µM H 2 O 2 and recovering in unsupplemented media versus those recovering in the physiological concentration of VitB12, the latter condition resulted in longer neurites, suggesting a potential beneficial effect. In contrast, a high dose of VitB12 did not improve recovery after H 2 O 2 insult, and the effects were comparable to that of the unsupplemented media (Fig. 1 D, E). Notably, the physiological VitB12 condition shows increased neurite length despite higher cell survival and cell number (Fig. 1 C). This argues against a sparse-culture artifact due to H 2 O 2 -induced cell loss and suggests that the neurite-elongation effect is not driven by reduced confluence. Since our system demonstrated substantial differences only after the insult with 50 µM H 2 O 2 , we focused on this concentration and did not further investigate the effects of the lower H 2 O 2 dose. Physiological Levels of Vitamin B12 Enhance Cell Survival and Neurite Elongation To corroborate the differences in cell death observed as a result of erythrosin B staining, we evaluated the expression levels of PARP1 (directly associated with DNA damage) [ 35 ], by WB (Fig. 2 A). Treatment with 50 µM H 2 O 2 , followed by recovery in either an unsupplemented medium or a high dose of VitB12, resulted in an increased relative abundance of the cleaved (inactive) form of PARP1. In contrast, cells recovering with the physiological levels of VitB12 exhibited a lower relative proportion of cleaved PARP1, indicating a potential protective effect of the treatment. This suggests that cell recovery in the physiological dose of VitB12 after exposure to 50 µM H 2 O 2 results in reduced apoptosis. This is in accord with the reduced caspase-3 activation, with PARP1 being one of its targets [ 35 ] (Fig. 3S ). Additionally, we measured the PCNA levels, which remained unchanged across all conditions, suggesting the absence of active cell proliferation (Fig. 2 A). Overall, the increased cell number observed during recovery with the physiological doses of VitB12 (Fig. 1 C) is a result of reduced cell death. Fig. 2. Open in a new tab The physiological dose of vitamin B12 enhances cell survival and neurite elongation during recovery. A The western blots and densitometry quantification of PARP1 full form, PARP1 cleaved form, PCNA and β-Actin. β-Actin was employed as the internal reference protein. The samples correspond to: Lane 1, differentiated SH-SY5Y cells in MEM containing 1% FBS; Lane 2, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Lane 3, differentiated SH-SY5Y cells in MEM containing 1% FBS and 1 μM VitB12; Lane 4, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 1 μM VitB12; Lane 5, differentiated SH-SY5Y cells in MEM containing 1% FBS and 0.01 μM VitB12; Lane 6, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12. The densitometric analysis was performed by evaluating the protein expression levels from the protein bands. For PARP1, the ratio of PARP1 cleaved to full form was quantified, and for PCNA, the protein expression levels were evaluated from the protein bands, followed by normalization with the bands of β-Actin. B The western blots and densitometry quantification of GAP-43 and β-Actin. The densitometric analysis was performed by evaluating the protein expression levels from the protein bands, followed by normalization with the bands of β-Actin. C Immunofluorescence microscopic images of GAP-43 at 24 h for the same conditions as that of the western blot, and the scale bar corresponds to 20 µm. D Immunofluorescence analysis of GAP-43 at 24 h where the aggregates of GAP-43 were measured as spot per µm of the neurite length. Data are from 3 biological replicates for the WB analysis and from 4 biological replicates for the immunofluorescence analysis, and is presented as mean ± SD. Statistical significance was determined using one-way ANOVA test, followed by Tukey’s test which compared the means of two or more independent groups: * p < 0.05, ** p < 0.01, *** p < 0.001 To corroborate the morphological data on neurite elongation, we biochemically measured the cellular levels of GAP-43 (Fig. 2 B). The cells cultured only in unsupplemented, high-dose, or physiological dose of VitB12 conditions did not result in significant differences. Cells exposed to 50 µM H 2 O 2 showed a general reduction of GAP-43, but the ones recovering in unsupplemented medium or under high-dose VitB12 conditions showed higher GAP-43 levels compared to the cells recovering in the physiological dose. To further investigate this, we immunolocalized GAP-43 on neurites and quantified the number of dots relative to neurite length (Fig. 2 C, D). Non-H 2 O 2 -insulted cells exhibit a similar number of GAP-43 dots per micrometer of neurite length. Conversely, after treatment with 50 µM H 2 O 2 , the recovery medium produced distinct outcomes: recovery in an unsupplemented medium did not significantly change the number of dots (although a decreasing trend is observable compared to its non-insulted counterpart), whereas both the physiological and high-dose treatments led to an increased number of dots (Fig. 2 C, D). The lack of correlation between the number of GAP-43 dots in neurites and the total protein levels detected by WB analysis could be attributed to differences in the subcellular localization of GAP-43 (distribution between the cell body and neurites). Thus, while the physiological dose of VitB12 induces a global reduction in GAP-43 protein levels, the concomitant increase in the number of dots per micrometer in neurites and the greater neurite elongation observed from morphological assessments (Fig. 1 E) suggests that the physiological doses of VitB12 effectively promote neurite elongation. The fact that recovery under high-dose conditions results in a comparable number of GAP-43 dots per micrometer of neurite length as the physiological dose, but with a greater amount of GAP-43 protein level, suggests that the cells recovering under high-dose conditions may still be in an early phase of GAP-43 accumulation before neurite elongation occurs. The Physiological Dose of Vitamin B12 Triggers an Early Increase in the Expression of Antioxidant Stress-Associated Genes in H 2 O 2 -Insulted SH-SY5Y Cells The morphological and molecular characterization of cellular survival and recovery parameters suggests a potential beneficial effect of the physiological dose of VitB12 in mitigating H 2 O 2 -induced damage. To gain deeper insight into the molecular mechanisms underlying the protective effects of VitB12, we analyzed the expression levels of key genes involved in antioxidative stress responses, including the mRNA levels of the transcription factor NF-E2 p45-related factor 2 ( NFE2L2 or NRF2 ), and that of its target genes encoding enzymes capable of shielding the cell from the adverse effects induced by oxygen radicals, including glutathione peroxidase 4 ( GPX4 ), NAD(P)H:quinone oxidoreductase 1 ( NQO1 ), superoxide dismutase 1 ( SOD1 ), and superoxide dismutase 2 ( SOD2 ) [ 36 ]. NRF2 activity is strictly regulated by imbalances in the cellular redox homeostasis, as oxidative insults determine its activation [ 37 ], thereby increasing the expression of GPX4 , which protects cells by reducing lipid hydroperoxides, preserving membrane integrity [ 38 ]; of NQO1 , enhancing antioxidant capacity as part of the NRF2-mediated response [ 39 ]; and of SOD1 and SOD2 , that convert superoxide radicals into less harmful molecules in the cytoplasm and the mitochondria, respectively [ 40 ]. Considering that mentioned genes could have different time-related dynamics for their expression, we decided to assess their expression at 2 h (early stage) and 24 h (later stage), the latter being the time frame used in most of the experiments in this study. Because early antioxidant transcriptional activation precedes morphological recovery, we interpret the 2 h gene-expression response as an early stress-response layer that may shape the consolidated recovery phenotypes quantified at 24 h (MTT viability and neurite outgrowth). To strengthen the early-phase interpretation, we complemented qRT-PCR with DCFDA and JC-1 readouts at 2 h (Figs. 4S – 5S ). Overall, antioxidant markers appear to be upregulated earlier in response to a physiological dose of VitB12 than with a high dose, following H 2 O 2 exposure. The distinct responses observed at these two concentrations are notable, as they suggest a faster recovery with the physiological dose, and a delayed response with the high dose of VitB12 (Fig. 3 A). This trend was further supported by the catalase (CAT) protein analysis, an enzyme that mitigates oxidative damage by converting H 2 O 2 into water and oxygen [ 41 ]. Considering that protein translation events are generally delayed relative to transcriptional activation [ 42 ], this analysis revealed an increase in the CAT levels only after 24 h of treatment with the physiological dose of VitB12 (Fig. 3 B). To complement the early transcriptional antioxidant response (2 h), we directly assessed cytosolic redox status and mitochondrial functional resilience during recovery. Specifically, DCFDA fluorescence imaging was used to quantify the fraction of cells showing elevated oxidant-dependent signal, and JC-1 was used as a functional readout of mitochondrial membrane potential (ΔΨm) at 2 h (Figs. 4S – 5S ). At 2 h, DCFDA fluorescent staining showed a reduction in the fraction of cells with elevated oxidant-dependent signal during recovery with VitB12, with the physiological dose bringing values closer to controls and the high dose producing a stronger suppression of the DCFDA-positive fraction. JC-1 analysis showed an increased red/green ratio specifically with the physiological dose in H 2 O 2 -insulted cells, consistent with a more polarized mitochondrial membrane potential (ΔΨm). Together with the 2 h gene-expression response, these assays provide complementary support that VitB12 dose influences early redox dynamics and mitochondrial functional status during recovery. Notably, the marked suppression of DCFDA positivity at the high dose suggests an early redox shift, highlighting that effective recovery likely depends on restoring an appropriate redox balance rather than maximally suppressing oxidant-dependent signals. Fig. 3. Open in a new tab The physiological dose of vitamin B12 activates antioxidative stress defenses earlier than the high dose in H 2 O 2 -insulted SH-SY5Y cells. A The qRT-PCR gene expression levels of NRF2, GPX4, NQO1, SOD1, and SOD2, at 2 h and 24 h, with respect to the housekeeping gene RPL34. The samples are: Condition 1, differentiated SH-SY5Y cells in MEM containing 1% FBS; Condition 2, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Condition 3, differentiated SH-SY5Y cells in MEM containing 1% FBS and 1 μM VitB12; Condition 4, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 1 μM VitB12; Condition 5, differentiated SH-SY5Y cells in MEM containing 1% FBS and 0.01 μM VitB12; Condition 6, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12. B The western blots of catalase and β-actin, with their corresponding densitometric analysis. The densitometric analysis was performed by evaluating the protein expression levels from the protein bands, followed by normalization with the bands of β-Actin. Data are from 3 biological replicates and are presented as mean ± SD. Statistical significance was determined using one-way ANOVA test, followed by Tukey’s test which compared the means of two or more independent groups: * p < 0.05, ** p < 0.01, *** p < 0.001 Physiological Dose of Vitamin B12 Reduces Succinate in H 2 O 2 -Insulted Cells Our observations indicate differences in cell death and neurite elongation after H 2 O 2 insult depending on the dose of VitB12 used during recovery. Considering the well-established role of VitB12 in metabolism [ 15 ], we decided to assess possible differences in the cellular metabolic response to these treatments using high-resolution NMR endo-metabolome analysis. This analysis allowed us to identify twelve amino acids (leucine, isoleucine, valine, alanine, arginine, glutamate, methionine, lysine, aspartate, tyrosine, phenylalanine, and glutamine), two organic acids (succinic acid and lactic acid), three choline derivatives (choline, phosphocholine, and glycerophosphocholine), and other compounds such as creatine, myo-inositol, taurine, and uridine (Table 3S ). Multivariate analyses, i.e., principal component analysis (PCA) and pairwise PERMANOVA (Tables 1 – 2S and Fig. 6S A), were performed on the NMR quantitative data. Neither method revealed statistically significant differences, likely due to their focus on capturing global data structures rather than subtle variations between specific groups. However, a visual trend of sample separation in the PCA score plot was observed between H 2 O 2 -insulted cells and their non-insulted counterparts when considered as overall groups. These results prompted us for further investigation using pairwise comparisons, which could be more sensitive for detecting specific group differences. Given the exploratory nature of this metabolomics layer and the limited statistical power inherent to a multi-group (six-condition) design, we used ANOVA p < 0.2 as a screening threshold to flag candidate metabolites showing trend-level differences. Importantly, ANOVA p < 0.2 was not interpreted as confirmatory significance; specific group differences were considered supported only when passing more stringent post hoc testing ( p < 0.05) (Fig. 4 ). Accordingly, pathway-level interpretation is presented as hypothesis-generating, given the limited number of quantified metabolites, and requires targeted validation. In the absence of H 2 O 2 insult, the physiological dose of VitB12 had limited effects compared to the unsupplemented condition, with a significant decrease in arginine; in contrast, the high dose of VitB12 induced more pronounced changes, including a significant decrease in methionine and an increase in uridine. H 2 O 2 -insulted cells recovering in unsupplemented medium, compared to their non-insulted counterpart, exhibited a decrease in alanine, arginine, choline, and valine, along with an increase in creatine, reflecting widespread disruption of metabolic pathways (Fig. 4 ). When VitB12 was administered after H 2 O 2 -induced stress, the recovery effects varied between physiological and high doses: specifically, recovery with high-dose VitB12 supplementation resulted in a reduction in isoleucine levels without significant changes in alanine, valine, or choline; in contrast, recovery with physiological doses of VitB12 supplementation led to a decrease in succinate only. Furthermore, H 2 O 2 -insulted cells recovering with physiological levels of VitB12 showed elevated levels of phosphorylcholine and taurine compared to non-insulted cells cultured in unsupplemented medium (Fig. 4 ). Next, we queried MetaboAnalyst.ca to perform a pathway analysis, considering the metabolites that changed following the H 2 O 2 treatment, and recovering in a physiological dose VitB12 supplementation. Specifically, the analysis included alanine, arginine, choline, valine, creatine, succinate, phosphorylcholine, and taurine. The pathway analysis identified the alanine, aspartate, and glutamate metabolism pathway as the most significantly affected ( p = 0.0078265) (Fig. 6S B), which involves alanine ( C00042 ) and succinate ( C00041 ). Alanine and succinate play a crucial role in maintaining mitochondrial balance in the neurons, primarily through energy metabolism and the Krebs cycle. Alanine, a non-essential amino acid, is converted into pyruvate, which can either enter glycolysis or be transformed into acetyl-CoA to fuel the Krebs cycle, thereby influencing mitochondrial energy production. Similarly, succinate, a key metabolite in the Krebs cycle, can enhance ATP production by directly supplying electrons to the electron transport chain, thereby supporting mitochondrial function [ 43 ]. Overall, NMR data suggests a potential enhancement in mitochondrial activity when cells were recovered in a physiological dose of VitB12. Fig. 4. Open in a new tab The physiological dose of vitamin B12 decreases succinate levels in H 2 O 2 -insulted SH-SY5Y cells. The metabolic profile alterations (differences in the metabolites) are from the endo-metabolome analysis. The conditions correspond to: Condition 1, differentiated SH-SY5Y cells in MEM containing 1% FBS; Condition 2, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Condition 3, differentiated SH-SY5Y cells in MEM containing 1% FBS and 1 μM VitB12; Condition 4, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 1 μM VitB12; Condition 5, differentiated SH-SY5Y cells in MEM containing 1% FBS and 0.01 μM VitB12; Condition 6, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12. Data are from 3 biological replicates and are presented as mean ± SD. Metabolite abundances were normalized to the total metabolite sum (sum of all metabolites per spectrum) and auto-scaled prior to statistical analysis. Statistical significance was determined using one-way ANOVA ( p < 0.2), followed by Tukey's test which compared the means of two or more independent groups: * p < 0.05, ** p < 0.01, *** p < 0.001 VitB12 at Physiological Levels Optimizes Mitochondrial Morphodynamics The role of VitB12 in mitochondrial activity is well-documented [ 44 ]. Interestingly, our findings suggest a potential improvement in mitochondrial function, following H 2 O 2 -induced stress and subsequent recovery only with the physiological dose of VitB12. Based on these observations, we decided to investigate potential changes in the mitochondrial morphodynamics. Mitochondria were stained using MitoTracker and the microscopic images were analyzed using the MiNA plugin of the Fiji software, which allowed us to quantify various key mitochondrial morphology parameters, including the mitochondrial footprint (the total area of the image occupied by the mitochondrial signal), the branch length mean (the average length of the lines used to represent mitochondrial structures), and the network branch mean (the average number of attached lines used to represent each structure) [ 26 ]. We evaluated these parameters both across the whole cell surface (including the cell body and neurites) and also specifically to neurites. Based on the MiNA analysis, there was no significant variation in the mitochondrial footprint of neurites and whole cells when treated with H 2 O 2 and allowed to recover in either unsupplemented medium or supplemented with VitB12 media (Fig. 5 A, B). In terms of the mean branch length, no noticeable change was detected in the whole cells. However, on analyzing the neurites specifically, we observed a significant decrease in this parameter for the H 2 O 2 -exposed cells recovering in unsupplemented medium compared to non-exposed cells in the same medium (Fig. 5 A, B). This reduction may be linked to an increase in fragmented networks resulting from mitochondrial fission (as inferred). Interestingly, when the H 2 O 2 -exposed cells were allowed to recover in a physiological dose of VitB12, the neurite branch length mean was significantly higher compared to the H 2 O 2 -exposed cells recovering in unsupplemented medium (Fig. 5 A, B). This suggests a potential decrease in mitochondrial fragmentation and an overall improvement in the neurite length. Additionally, regarding the mean number of network branches, a general decline was observed following the H 2 O 2 exposure (Fig. 5 A, B). This decrease implies that mitochondrial networking was disrupted due to the H 2 O 2 exposure, leading to mitochondrial fission and the formation of fragmented structures. Furthermore, in both the whole cells and neurites, between the group of non-H 2 O 2 -insulted cells, a physiological dose of VitB12 determined the highest level of mitochondrial networking (Fig. 5 A, B). The increase in network branching may reflect enhanced mitochondrial networking and structural remodeling, consistent with improved mitochondrial organization in the presence of a physiological dose of VitB12. Overall, across the mitochondrial network parameters assessed, treatment with a physiological dose of VitB12 was associated with improved mitochondrial morphodynamics [ 45 ]. Importantly, these imaging-based observations are consistent with the direction of the exploratory NMR endo-metabolome findings (Fig. 4 ), providing convergent support across orthogonal approaches. Fig. 5. Open in a new tab The physiological concentration of vitamin B12 enhances mitochondrial morphodynamics in H 2 O 2 insulted SH-SY5Y cells. A Fluorescence microscopic images of the MitoTracker-stained (the scale bar corresponds to a length of 20 µm) and B relative mitochondrial analysis (performed using the plugin mitochondrial network analysis, MiNA, of the ImageJ software; the plots report quantification of the mitochondrial footprint (in µm2), branch length mean (in µm), and network branches mean (as counts) parameters of the individual cells and neurites. The conditions correspond to: Condition 1, differentiated SH-SY5Y cells in MEM containing 1% FBS; Condition 2, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Condition 3, differentiated SH-SY5Y cells in MEM containing 1% FBS and 1 μM VitB12; Condition 4, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 1 μM VitB12; Condition 5, differentiated SH-SY5Y cells in MEM containing 1% FBS and 0.01 μM VitB12; Condition 6, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12. Data are from 4 biological replicates and are presented as mean ± SD. Statistical significance was determined using one-way ANOVA test, followed by Tukey's test which compared the means of two or more independent groups: * p < 0.05 The Recovery in a Physiological Dose of Vitamin B12 After H 2 O 2 Insult Optimizes Lipid Composition and Promotes Formation of Lipid Droplets (LDs) The decrease in succinate levels observed through endo-metabolome analysis, along with improvements in mitochondrial morphodynamics detected by MitoTracker, collectively indicate enhanced mitochondrial organization and activity during the recovery with a physiological dose of VitB12 after H 2 O 2 -insult. To gain deeper insight into the biochemical modifications, we conducted a single-cell Raman spectroscopic (SCRS) analysis, a powerful and label-free tool that enables biochemical profiling of individual cells without the need for external markers [ 28 , 46 – 49 ]. SCRS data (mean of Raman spectra reported in Fig. 6 and 7S ), obtained by analyzing 1 μm 2 regions of individual cell surfaces, were subjected to PCA and pairwise PERMANOVA. PCA results showed that the first two principal components accounted for a substantial proportion of the total variance, with PC1 explaining 44.15% and PC2 16.36% (Fig. 6 A, Table 1 ). The corresponding biplot (Fig. 6 A) revealed distinct spectral features contributing to this variance, notably Raman shifts at 3190 cm⁻ 1 and 3192 cm⁻ 1 , strongly associated with PC1 and attributed to O–H and N–H stretching vibrations linked to water content and protein hydration [ 28 , 46 – 49 ]. Additional discriminative features included a shift at 2768 cm⁻ 1 , indicative of lipid-related CH overtones, and a cluster of shifts between 2196 and 2347 cm⁻ 1 , corresponding to C≡C and C≡N bonds—suggestive of alterations in lipid composition and potential lipid peroxidation [ 28 , 46 – 49 ]. Raman shifts within the Amide I region (1653–1657 cm⁻ 1 ) and in the protein backbone region (940–966 cm⁻ 1 ) further indicated changes in protein conformation and organization [ 28 , 46 – 49 ]. Then, we applied pairwise PERMANOVA to quantitatively assess which group comparisons showed significant differences in their overall spectral profiles (Table 2 ). Significant differences were observed across all experimental comparisons, except between H 2 O 2 -insulted cells recovering with a physiological dose of VitB12 versus those recovering with a high dose. The spectral variations and statistical outcomes indicate that the experimental groups can be clearly distinguished based on global cellular chemical composition, particularly reflecting alterations in protein structure and lipid composition associated with oxidative stress and recovery. In addition, endo-metabolome analysis revealed elevated levels of phosphorylcholine and taurine in cells exposed to H 2 O 2 and subsequently treated with a physiological dose of VitB12, compared to non-insulted cells cultured in unsupplemented medium (Fig. 4 ). Overall, the combined evidence from SCRS and endo-metabolome analyses suggests that physiological levels of VitB12 may contribute not only to the stabilization of membrane integrity but also to broader improvements in lipid metabolism [ 50 – 52 ]. Fig. 6. Open in a new tab The physiological dose of vitamin B12 improves cell lipid composition in H 2 O 2 insulted-SH-SY5Y cells as revealed by single-cell Raman spectroscopy. A The biplot denoting the PCA which reveals the distribution of different Raman peaks with colors indicating different experimental groups. PC1 accounts for 44.15% and PC2 accounts for 16.36% of the total variance. B The ratios of 2851 cm⁻ 1 /2930 cm⁻ 1 , 2965 cm⁻ 1 /2930 cm⁻ 1 , 3015 cm⁻ 1 /2930 cm⁻ 1 , and 3015 cm⁻ 1 /2965 cm⁻ 1 calculated considering the different Raman peaks to identify the extent of lipid remodeling. The conditions correspond to: Condition 1, differentiated SH-SY5Y cells in MEM containing 1% FBS; Condition 2, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Condition 3, differentiated SH-SY5Y cells in MEM containing 1% FBS and 1 μM VitB12; Condition 4, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 1 μM VitB12; Condition 5, differentiated SH-SY5Y cells in MEM containing 1% FBS and 0.01 μM VitB12; Condition 6, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12. Data are from 4 different coverslips and are presented as mean ± SD. Statistical significance was determined using one-way ANOVA test, followed by Tukey’s test which compared the means of two or more independent groups: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 Table 1. PCA loadings of Raman shifts from single-cell Raman spectroscopy (SCRS) analysis Raman shift (cm⁻ 1 ) PC1 PC2 Raman shift (cm⁻ 1 ) PC1 PC2 Raman shift (cm⁻ 1 ) PC1 PC2 Raman shift (cm⁻ 1 ) PC1 PC2 211 −0.061282 0.088356 753 −0.085903 0.10886 1446 0.11588 −0.091705 2375 −0.11734 −0.11246 295 −0.12094 0.012272 778 −0.094738 0.064678 1447 0.11603 −0.089076 2427 −0.12981 −0.064982 310 −0.12314 −0.0034399 822 −0.10034 0.080785 1572 −0.019543 −0.10572 2466 −0.13307 −0.044273 338 −0.11902 −0.012586 849 0.019683 0.10504 1573 −0.020738 −0.10619 2512 −0.13509 −0.035047 371 −0.12769 −0.033029 882 −0.091368 −0.008055 1574 −0.021597 −0.10656 2550 −0.13502 −0.019108 400 −0.12344 −0.064977 940 −0.10693 −0.13685 1576 −0.018503 −0.10971 2608 −0.13008 0.021928 411 −0.11354 −0.07304 966 −0.093353 −0.14714 1653 0.092143 −0.15671 2609 −0.13157 0.019968 444 −0.11114 −0.080762 999 0.041772 −0.034468 1654 0.088185 −0.16313 2650 −0.12009 0.065013 470 −0.11895 −0.094316 1028 −0.092932 −0.086072 1655 0.08435 −0.16904 2683 −0.11745 0.084504 476 −0.12678 −0.079831 1049 −0.09836 −0.034123 1656 0.081652 −0.17371 2685 −0.11158 0.091968 501 −0.10925 −0.11171 1053 −0.096422 −0.066538 1657 0.07926 −0.17774 2728 −0.045361 0.11611 518 −0.10526 −0.053841 1094 −0.095217 −0.089041 1734 −0.072636 −0.093865 2729 −0.052822 0.12119 521 −0.09946 −0.042036 1123 −0.062166 −0.04645 1802 −0.12627 −0.047946 2730 −0.060853 0.12379 534 −0.05223 0.033734 1172 −0.11859 −0.0011121 1864 −0.1309 −0.022254 2731 −0.068274 0.12267 539 −0.059155 0.035412 1202 −0.080399 −0.050212 1921 −0.13464 −0.010929 2768 −0.10558 0.13246 542 −0.070782 0.038377 1248 −0.043288 −0.11013 2006 −0.13763 −0.034853 2929 0.1326 0.085308 546 −0.093408 0.030363 1258 −0.032924 −0.14161 2083 −0.13376 −0.050582 2930 0.13248 0.085422 576 −0.11169 0.07842 1260 −0.034554 −0.13799 2121 −0.1291 −0.072611 2931 0.13243 0.085143 596 −0.11831 0.072616 1297 0.03283 −0.11098 2137 −0.13081 −0.082755 2932 0.13211 0.085669 620 −0.10501 0.11951 1303 0.021991 −0.10997 2196 −0.11534 −0.12734 3055 −0.022008 0.12258 625 −0.12399 0.096226 1332 −0.013752 −0.077815 2271 −0.11088 −0.13221 3056 −0.018859 0.12017 640 −0.10668 0.10333 1368 −0.029685 0.0092186 2301 −0.10451 −0.14942 3057 −0.016732 0.11673 667 −0.096917 0.1231 1442 0.11345 −0.09883 2324 −0.1055 0.093328 3058 −0.015158 0.1124 679 −0.10102 0.11484 1443 0.11465 −0.096681 2346 −0.10881 −0.13343 3190 −0.025282 0.2018 722 −0.098478 0.074155 1444 0.11536 −0.094691 2347 −0.10933 −0.13244 3192 −0.019949 0.20471 747 −0.08505 0.10272 1445 0.11562 −0.093626 2372 −0.11866 −0.10904 Open in a new tab Table 2. Pair-wise PERMANOVA results from single-cell Raman spectroscopy Comparison F.model R 2 p val p.adj 0.010 µM VitB12 vs 1 µM VitB12 32.10000 0.59335 0.00100 0.00214 0.010 µM VitB12 vs Ctrl 56.30400 0.74769 0.00100 0.00214 0.010 µM VitB12 vs 50 µM H 2 O 2 2.77480 0.21721 0.01300 0.01625 0.010 µM VitB12 vs 50 µM H 2 O 2 + 0.010 µM VitB12 11.85400 0.37213 0.00100 0.00214 0.010 µM VitB12 vs 50 µM H 2 O 2 + 1 µM VitB12 5.19350 0.20614 0.01300 0.01625 1 µM VitB12 vs Ctrl 9.25320 0.30586 0.00300 0.00500 1 µM VitB12 vs 50 µM H 2 O 2 11.80100 0.33910 0.00100 0.00214 1 µM VitB12 vs 50 µM H 2 O 2 + 0.010 µM VitB12 12.22000 0.35711 0.00100 0.00214 1 µM VitB12 vs 50 µM H 2 O 2 + 1 µM VitB12 8.73890 0.45423 0.00100 0.00214 Ctrl vs 50 µM H 2 O 2 22.45100 0.52887 0.00100 0.00214 Ctrl vs 50 µM H 2 O 2 + 0.010 µM VitB12 3.70170 0.29143 0.01200 0.01625 Ctrl vs 50 µM H 2 O 2 + 1 µM VitB12 16.40600 0.46336 0.00200 0.00375 50 µM H 2 O 2 vs 50 µM H 2 O 2 + 0.010 µM VitB12 4.42320 0.17398 0.03100 0.03577 50 µM H 2 O 2 vs 50 µM H 2 O 2 + 1 µM VitB12 3.66560 0.14861 0.03800 0.04071 50 µM H 2 O 2 + 0.010 µM VitB12 vs 50 µM H 2 O 2 + 1 µM VitB12 1.38880 0.06493 0.23900 0.23900 Open in a new tab To further investigate the observations described above, we focused on specific Raman spectral features related to lipid composition. In particular, the Raman shift at 2851 cm⁻ 1 corresponds to the symmetric CH 2 stretching mode in lipids; the shift at 2965 cm⁻ 1 is associated with cholesteryl esters; and the shift at 3015 cm⁻ 1 is attributed to ═CH stretching in unsaturated lipids [ 47 , 53 ]. Additionally, the Raman shift at 2930 cm⁻ 1 , corresponding to the symmetric CH₃ stretch in proteins, was used as an internal reference for normalization in subsequent analyses [ 47 , 53 ]. The ratio of the 2851 cm⁻ 1 Raman shift (lipids) to the 2930 cm⁻ 1 shift (proteins) was used to assess the overall lipid-to-protein balance. With the exception of the comparison between non-stressed cells cultured in high-dose VitB12 and those in unsupplemented medium, no significant differences were observed, suggesting a comparable distribution of total lipid/protein content across all recovery conditions (Fig. 8S ). The ratios of the 2965 cm⁻ 1 Raman shift (cholesteryl esters) to the 2930 cm⁻ 1 shift (proteins) and of the 3015 cm⁻ 1 shift (unsaturated lipids) to 2930 cm⁻ 1 showed some variation across conditions (Fig. 8S ). However, to better highlight changes in relative lipid composition, we focused on the ratio of 3015 cm⁻ 1 to 2965 cm⁻ 1 (Fig. 6 B). This ratio significantly increased in cells recovering with a physiological dose of VitB12 compared to those recovering without supplementation after H 2 O 2 insult. This finding suggests a relative enrichment of unsaturated lipids over cholesteryl esters under recovery conditions supported by physiological levels of VitB12 (Fig. 6 B). Generally, under oxidative stress conditions, alterations in lipid composition can help preserve membrane fluidity and integrity, thereby supporting cell survival [ 54 ]. To better characterize this phenomenon, we focused on the two experimental groups that exhibited the most prominent differences: H 2 O 2 -insulted cells recovering in unsupplemented medium and those recovering in medium supplemented with physiological levels of VitB12. We generated intensity maps of specific Raman shifts corresponding to the lipid signals previously mentioned. The 2851 cm⁻ 1 shift revealed distinct regions of maximal intensity (Fig. 7 A, B), which, according to Pacia and team [ 53 ], are indicative of lipid droplets (LDs). This observation enabled us to investigate lipid composition in two distinct cellular compartments: the lipid-rich regions corresponding to LDs and the surrounding membrane-associated lipid areas, which primarily reflect the plasma membrane composition. Fig. 7. Open in a new tab Raman mapping analysis reveals increased unsaturated lipid content in lipid droplets during recovery with physiological vitamin B12 supplementation. A Raman intensity map for − Raman shift at 2851 cm −1 (lipids), 2930 cm −1 (proteins), 2965 cm −1 (cholesteryl esters), and 3015 cm −1 (unsaturated lipids). B Selected segment used for profile analysis (yellow line), showing two prominent intensity peaks corresponding to LDs. C Intensity profiles along the selected segment for Raman shifts at 2851 cm −1 (lipids), 2930 cm −1 (proteins), 2965 cm −1 (cholesteryl esters), and 3015 cm −1 (unsaturated lipids, and 3015/2965 cm −1 ratio. The samples correspond to: Condition 1, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Condition 2, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12. For panel A, the scale bar indicates 10 µm, corresponding to 72 pixels; for panel B, the scale bar indicates 2.5 µm, also corresponding to 72 pixels To standardize our analysis, we used Fiji software to extract intensity profiles from a segment containing two high-intensity regions at 2851 cm⁻ 1 (Fig. 7 B). We then analyzed these profiles for the other Raman shifts of interest (Fig. 7 C). At the LD locations, the 2930 cm⁻ 1 signal appeared consistent between the two peaks identified in each condition, suggesting a stable protein distribution under both treatment conditions. Interestingly, opposite trends were observed for the 2965 cm⁻ 1 shift (cholesteryl esters) and the 3015 cm⁻ 1 shift (unsaturated lipids) at the LD locations between the two groups. Specifically, the 3015 to 2965 cm⁻ 1 ratio decreased in the regions corresponding to LDs in cells recovering in unsupplemented medium, whereas it increased in cells recovering with a physiological dose of VitB12. This suggests a relative enrichment of unsaturated lipids over cholesterol esters within LDs under VitB12-supplemented recovery conditions (Fig. 7 C). It is worth noting, however, that along the entire analyzed segment, the overall 3015 to 2965 cm⁻ 1 ratio was higher in cells recovering in unsupplemented medium compared to those recovering with a physiological dose of VitB12, thus not aligning with the SCRS analysis performed on 1-μm 2 regions of individual cell surfaces. This discrepancy may be attributed to differences in the quantity or spatial extent of lipid droplets between the two conditions, which could disproportionately influence the overall Raman signal contribution. To evaluate this possibility, we assessed LD content directly by performing Oil Red O (ORO) staining, a fat-soluble diazo dye commonly used to label neutral lipids and quantify lipid accumulation [ 29 ]. Following ORO staining, we quantified two lipid-related parameters across all treatment groups using ImageJ software: the number of LDs per nucleus and the average surface area per LD. Our analysis revealed that, although the average surface area per LD remained unchanged, the number of LDs per nucleus increased in cells recovering with a physiological dose of VitB12 compared to the unsupplemented condition (Fig. 8 A, B). It is plausible that this increased abundance contributes additively to the overall Raman signal. Consequently, the 3015 to 2965 cm −1 ratio measured over broader cell areas by SCRS is elevated due to the cumulative signal originating from a larger population of LDs. Fig. 8. Open in a new tab The recovery in a physiological dose of vitamin B12 after H 2 O 2 insult promotes lipid droplet (LD) formation. A Microscopic images of the ORO-stained SH-SY5Y differentiated cells obtained for the different concentrations of H 2 O 2 and VitB12 after recovery in their respective controls and the scale bar corresponds to a length of 20 µm, and B the quantification of the number of LDs per nuclei and the average surface area per LDs across all the treatment conditions, using the ImageJ software. The samples correspond to: Condition 1, differentiated SH-SY5Y cells in MEM containing 1% FBS; Condition 2, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS; Condition 3, differentiated SH-SY5Y cells in MEM containing 1% FBS and 1 μM VitB12; Condition 4, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 1 μM VitB12; Condition 5, differentiated SH-SY5Y cells in MEM containing 1% FBS and 0.01 μM VitB12; Condition 6, differentiated SH-SY5Y cells treated with 50 μM H 2 O 2 , followed by recovery in MEM containing 1% FBS and 0.01 μM VitB12. Data are from 4 biological replicates and are presented as mean ± SD. For the quantification of the number of LDs, a Shapiro-Wilk test was performed to identify that the data was not normally distributed. Therefore, this allowed us to perform a non-parametric statistical test, Mann-Whitney U test, to compare the significance between the different treatment groups. All data were considered statistically significant at * p < 0.05 It is important to note that neuronal cells are typically not considered energy-storing cells, as they lack significant glycogen or LD reserves [ 55 ]. The combination of an enrichment in unsaturated fatty acids and an increase in LD formation following the physiological dose of VitB12 supplementation presents several interesting possibilities. Under conditions of oxidative stress, an increased unsaturated fatty acid content in LDs could reflect an adaptive response and may contribute to buffering oxidative stress, thereby mitigating H 2 O 2 -induced damage, but also by replenishing cell membranes with more fluid lipids, thereby helping to preserve membrane integrity and fluidity [ 56 ]. Conclusions Here, we used an in vitro neural-like model of differentiated SH-SY5Y cells exposed to hydrogen peroxide (H 2 O 2 ) to investigate the effects of physiological (0.01 µM) versus high (1 µM) doses of VitB12 on neural recovery. Our results demonstrate that a physiological dose significantly enhances cell viability and neurite outgrowth compared to a high dose. At 2 h of recovery, notably, this dose triggered earlier activation of antioxidant gene expression and increased the JC-1 R/G ratio (ΔΨm), suggesting a more rapid cellular response to H 2 O 2 insult. In contrast, high-dose VitB12 markedly suppressed DCFDA positivity after H 2 O 2 , underscoring the importance of maintaining an appropriate redox balance. At 24 h of recovery, metabolic analysis (exploratory NMR endo-metabolomics) suggested reduced intracellular succinate levels with the physiological dose. Consistently, mitochondrial network metrics indicated remodeling toward a more interconnected morphology, reflected by greater mean branch length in the mitochondrial network. Taken together, these convergent observations across orthogonal approaches support a dose-dependent mitochondrial adaptation during recovery, while acknowledging that the NMR layer is exploratory and will benefit from future targeted validation. This was accompanied by lipid remodeling, as detected by single-cell Raman spectroscopy (SCRS), indicating increased levels of unsaturated lipids. In parallel, Oil Red O (ORO) staining revealed a higher number of lipid droplets (LDs), suggesting active lipid-based stress responses. Importantly, the accumulation of unsaturated lipids and LDs may represent additional late-stage defense mechanisms against H 2 O 2 -induced oxidative damage. These findings should be interpreted considering model- and time-related limitations (RA-differentiated SH-SY5Y cells and predominantly 24-h recovery endpoints) and will require validation in primary neurons/in vivo with expanded time-course analyses; mechanistic causality will further benefit from targeted genetic perturbations of key antioxidant and lipid-droplet regulators. In summary, our findings indicate that a physiological dose of VitB12 orchestrates a temporally coordinated response to oxidative stress, characterized by the early activation of antioxidant defenses—unlike the delayed response observed with the high dose—and followed, at later time points, by mitochondrial and lipid-mediated adaptive mechanisms. This aligns with previous reports showing that VitB12 can support neuronal structural recovery and mitigate oxidative injury [ 10 – 14 ]. Similar beneficial associations between VitB12 status/supplementation and cognitive or neuroprotective outcomes have also been reported in vivo, supporting the broader relevance of VitB12 for neuronal resilience [ 10 – 12 ]. Importantly, our study extends this literature by directly comparing a physiological (low-nanomolar) dose with a higher dose and demonstrating that the timing and nature of the recovery program are dose-dependent within the same experimental framework. It is important to note that studies have shown that VitB12 at a high dose can have very specific effect; for instance, it can modulate LRRK2 kinase activity through allosteric regulation, conferring neuroprotection in models of Parkinson’s disease [ 15 , 57 ]. This suggests that, while high doses of VitB12 may engage specific signaling pathways contributing to neuroprotection, they may also affect distinct metabolic routes that are not conducive to recovery from oxidative stress, particularly that induced by H 2 O 2 , highlighting the complexity of dose-dependent effects (reviewed in [ 15 ]). Although these findings should be interpreted considering model- and time-related limitations (RA-differentiated SH-SY5Y cells and 2–24-h recovery endpoints) and will require validation in primary neurons/in vivo with expanded time-course analyses, they provide a promising rationale that different VitB12 doses may activate distinct protective mechanisms, underscoring the importance of tailoring the choice between high and low doses to the type and context of cellular damage, as dose requirements may be context-dependent in redox-sensitive recovery settings. Supplementary Information Below is the link to the electronic supplementary material. ESM 1 (5.3MB, docx) (DOCX 5.28 MB) ESM 2 (807.4KB, pdf) (DOCX 807 KB) Acknowledgements The authors gratefully acknowledge Emeritus Univ.-Prof. Dr Bernhard Kräutler for generously sharing his extensive expertise in vitamin research. Author Contributions CRediT authorship contribution statement A.R.M.: Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing. L.B.: Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft. A.P.: Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft. G.D.M.: Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft. E.S.: Formal analysis, Methodology, Validation, Visualization, Software. I.S.: Software. R. Stefanelli: Investigation. E.G.: Investigation. F.M.: Investigation. L.M.: Writing – review & editing. M.R.: Writing – review & editing. A.D.J.: Writing – review & editing. E.M.: Writing – review & editing. A.M.T.: Writing – review & editing. L.A.: Writing – review & editing. P.L.R.: Formal analysis, Visualization, Writing – original draft. D.P.: Writing – review & editing. V.C. and M.F.: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. Funding Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement. This work was supported by Sapienza University of Rome: grants AR123188A13167D9 and AR224190736FCDC1 to A.R.M.; grant RM12117A86B6FF27 to P.L.R.; grants RP12117A5C8B6DC1, P1221816749A2A8, and RM124190EE61B8D3 to M.F. This research received no external funding. Data Availability The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information files. Should any raw data files be needed in another format they are available from the corresponding author upon reasonable request. Declarations Competing Interests The authors declare no competing interests. Footnotes Highlights • A physiological dose of VitB12 enhances neural recovery after oxidative insult, unlike a high dose. • A physiological dose of VitB12 activates early antioxidant-defense mechanisms. • Later, a physiological dose of VitB12 improves mitochondria and lipid droplets. • A physiological dose of VitB12 enriches lipid droplets with unsaturated lipids, potentially contributing to oxidative-stress buffering. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. V. Cavallucci and M. Fidaleo contributed equally to this work. References 1. Allen LH (2012) Vitamin B-12. Adv Nutr 3:54–55. 10.3945/an.111.001370 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 2. Brown KL (2005) Chemistry and enzymology of vitamin B12. Chem Rev 105:2075–2149 [ DOI ] [ PubMed ] [ Google Scholar ] 3. Kräutler B (2012) Biochemistry of B12-cofactors in human metabolism. Sub-Cellular Biochemistry. Springer, New York, pp 323–346 [ DOI ] [ PubMed ] [ Google Scholar ] 4. Osman D, Cooke A, Young TR (2021) The requirement for cobalt in vitamin B12: a paradigm for protein metalation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1868:118896. 10.1016/j.bbamcr.2020.118896 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 5. Andrès E, Federici L, Affenberger S, Vidal-Alaball J, Loukili NH, Zimmer J, Kaltenbach G (2007) B12 deficiency: a look beyond pernicious anemia. J Fam Pract 56(7):537–542 [ PubMed ] [ Google Scholar ] 6. Henríquez P, Doreste J, Deulofeu R (2006) Nutritional determinants of plasma total homocysteine distribution in the Canary Islands. Eur J Clin Nutr 61:111–118. 10.1038/sj.ejcn.1602490 [ DOI ] [ PubMed ] [ Google Scholar ] 7. Lindenbaum J, Rosenberg I, Wilson P (1994) Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 60:2–11. 10.1093/ajcn/60.1.2 [ DOI ] [ PubMed ] [ Google Scholar ] 8. Vidal-Alaball J, Butler C, Cannings-John R et al (2005) Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 10.1002/14651858.CD004655.pub2 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 9. Wang H, Li L, Qin LL et al (2018) Oral vitamin B 12 versus intramuscular vitamin B 12 for vitamin B 12 deficiency. Cochrane Database of Systematic Reviews. 10.1002/14651858.CD004655.pub3 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 10. Barman B, Kushwaha A, Thakur MK (2021) Vitamin B12-folic acid supplementation regulates neuronal immediate early gene expression and improves hippocampal dendritic arborization and memory in old male mice. Neurochem Int 150:105181. 10.1016/J.NEUINT.2021.105181 [ DOI ] [ PubMed ] [ Google Scholar ] 11. Wu F, Xu K, Liu L et al (2019) Vitamin B12 enhances nerve repair and improves functional recovery after traumatic brain injury by inhibiting ER stress-induced neuron injury. Front Pharmacol. 10.3389/fphar.2019.00406 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 12. Yadav P, Nasir F, Sivanandam TM (2024) Neuroprotective effect of vitamin B12 supplementation on cognitive functions and neuronal morphology at different time intervals after traumatic brain injury in male Swiss albino mice. Neurochem Int 180:105869. 10.1016/J.NEUINT.2024.105869 [ DOI ] [ PubMed ] [ Google Scholar ] 13. Zhong L, Zhou J, Chen X, Lou Y, Liu D, Zou X, Yang B, Yin Y, Pan Y (2016) Quantitative proteomics study of the neuroprotective effects of B12 on hydrogen peroxide-induced apoptosis in SH-SY5Y cells. Sci Rep. 6:22635. 10.1038/srep22635 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 14. Theiss EL, Griebsch LV, Lauer AA et al (2022) Vitamin B12 attenuates changes in phospholipid levels related to oxidative stress in SH-SY5Y cells. Cells. 10.3390/cells11162574 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 15. Mathew AR, Di Matteo G, La Rosa P et al (2024) Vitamin B12 Deficiency and the Nervous System: Beyond Metabolic Decompensation—Comparing Biological Models and Gaining New Insights into Molecular and Cellular Mechanisms. Int J Mol Sci. 10.3390/ijms25010590 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 16. Fidaleo M, Tacconi S, Sbarigia C et al (2021) Current nanocarrier strategies improve vitamin b12 pharmacokinetics, ameliorate patients’ lives, and reduce costs. Nanomaterials 11:1–19 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 17. Brescoll J, Daveluy S (2015) A review of vitamin B12 in dermatology. Am J Clin Dermatol 16:27–33 [ DOI ] [ PubMed ] [ Google Scholar ] 18. Jin Y, Wang H (2019) Naringenin inhibit the hydrogen peroxide-induced SH-SY5Y cells injury through Nrf2/HO-1 pathway. Neurotox Res 36:796–805. 10.1007/s12640-019-00046-6 [ DOI ] [ PubMed ] [ Google Scholar ] 19. Yang R, Wei L, Fu QQ et al (2016) SOD3 ameliorates H2O2-induced oxidative damage in SH-SY5Y cells by inhibiting the mitochondrial pathway. Neurochem Res 41:1818–1830. 10.1007/s11064-016-1897-x [ DOI ] [ PubMed ] [ Google Scholar ] 20. Pemberton K, Mersman B, Xu F (2018) Using imageJ to assess neurite outgrowth in mammalian cell cultures: research data quantification exercises in undergraduate neuroscience lab. J Undergrad Neurosci Educ 16(2):A186–A194 [ PMC free article ] [ PubMed ] [ Google Scholar ] 21. Beckonert O, Keun HC, Ebbels TMD et al (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692–2703. 10.1038/nprot.2007.376 [ DOI ] [ PubMed ] [ Google Scholar ] 22. De Castro F, Stefàno E, De Luca E et al (2022) A NMR-based metabolomic approach to investigate the antitumor effects of the novel [Pt(η 1-C2H4OMe)(DMSO)(phen)]+(phen = 1,10-phenanthroline) compound on neuroblastoma cancer cells. Bioinorg Chem Appl. 10.1155/2022/8932137 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 23. Ingallina C, Di Matteo G, Spano M et al (2023) Byproducts of Globe Artichoke and Cauliflower Production as a new source of bioactive compounds in the Green Economy Perspective: an NMR study. Molecules 28:1363. 10.3390/molecules28031363 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 24. Spano M, Di Matteo G, Fernandez Retamozo CA et al (2023) A multimethodological approach for the chemical characterization of edible insects: the case study of Acheta domesticus . Foods 12:2331. 10.3390/foods12122331 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 25. Aranibar N, Borys M, Mackin NA et al (2011) NMR-based metabolomics of mammalian cell and tissue cultures. J Biomol NMR 49:195–206. 10.1007/s10858-011-9490-8 [ DOI ] [ PubMed ] [ Google Scholar ] 26. Leonard AP, Cameron RB, Speiser JL et al (2015) Quantitative analysis of mitochondrial morphology and membrane potential in living cells using high-content imaging, machine learning, and morphological binning. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1853:348–360. 10.1016/j.bbamcr.2014.11.002 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 27. Valente AJ, Maddalena LA, Robb EL et al (2017) A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. Acta Histochem 119:315–326. 10.1016/j.acthis.2017.03.001 [ DOI ] [ PubMed ] [ Google Scholar ] 28. Delfino I, Ricciardi V, Manti L et al (2019) Multivariate analysis of difference Raman spectra of the irradiated nucleus and cytoplasm region of SH-SY5Y human neuroblastoma cells. Sensors. 10.3390/s19183971 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 29. Xu JX, Fang K, Gao XR et al (2021) Resveratrol Protects SH-SY5Y Cells Against Oleic Acid-Induced Glucolipid Metabolic Dysfunction and Cell Injuries Via the Wnt/β-Catenin Signalling Pathway. Neurochem Res 46:2936–2947. 10.1007/s11064-021-03398-8 [ DOI ] [ PubMed ] [ Google Scholar ] 30. Kovalevich J, Langford D (2013) Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol 1078:9–21. 10.1007/978-1-62703-640-5_2 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 31. Lopes FM, Schröder R, Júnior M et al (2010) Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337:85–94. 10.1016/j.brainres.2010.03.102 [ DOI ] [ PubMed ] [ Google Scholar ] 32. Inada M, Toyoshima M, Kameyama M (1982) Brain content of cobalamin and its binders in elderly subjects. J Nutr Sci Vitaminol (Tokyo). 10.3177/jnsv.28.351 [ DOI ] [ PubMed ] [ Google Scholar ] 33. Fernàndez-Roig S, Lai SC, Murphy MM et al (2012) Vitamin B12 deficiency in the brain leads to DNA hypomethylation in the TCblR/CD320 knockout mouse. Nutr Metab Lond. 10.1186/1743-7075-9-41 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 34. (2009) Scientific Opinion on the use of cobalt compounds as additives in animal nutrition. EFSA Journal 7:. 10.2903/j.efsa.2009.1383 35. Lee SY, Kim CH, Hwang BS et al (2020) Protective effects of oenothera biennis against hydrogen peroxide-induced oxidative stress and cell death in skin keratinocytes. Life 10:1–12. 10.3390/life10110255 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Retracted ] 36. La Rosa P, Petrillo S, Bertini ES, Piemonte F (2020) Oxidative stress in DNA repeat expansion disorders: a focus on NRF2 signaling involvement. Biomolecules. 10.3390/biom10050702 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 37. Yu C, Xiao JH (2021) The keap1-Nrf2 system: A mediator between oxidative stress and aging. Oxid Med Cell Longev 2021:6635460. 10.1155/2021/6635460 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 38. Ma T, Du J, Zhang Y, Wang Y, Wang B, Zhang T (2022) GPX4-independent ferroptosis—a new strategy in disease’s therapy. Cell Death Discov 8:434. 10.1038/s41420-022-01212-0 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 39. Jo HS, Kim DS, Ahn EH et al (2016) Protective effects of Tat-NQO1 against oxidative stress-induced HT-22 cell damage, and ischemic injury in animals. BMB Rep 49:617–622. 10.5483/BMBRep.2016.49.11.117 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 40. Gupta SV, Campos L, Schmidt KH (2023) Mitochondrial superoxide dismutase Sod2 suppresses nuclear genome instability during oxidative stress. Genetics. 10.1093/genetics/iyad147 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 41. Fidaleo M, Fracassi A, Zuorro A et al (2014) Cocoa protective effects against abnormal fat storage and oxidative stress induced by a high-fat diet involve PPARα signalling activation. Food Funct 5:2931–2939. 10.1039/C4FO00616J [ DOI ] [ PubMed ] [ Google Scholar ] 42. Schwanhäusser B, Busse D, Li N et al (2011) Global quantification of mammalian gene expression control. Nature 473:337–342. 10.1038/nature10098 [ DOI ] [ PubMed ] [ Google Scholar ] 43. Zwingmann C, Richter-Landsberg C, Brand A, Leibfritz D (2000) NMR spectroscopic study on the metabolic fate of [3-13C]Alanine in astrocytes, neurons, and cocultures: implications for glia-neuron interactions in neurotransmitter metabolism. Glia 32:286–303. 10.1002/1098-1136(200012)32:3<286::AID-GLIA80>3.0.CO;2-P [ DOI ] [ PubMed ] [ Google Scholar ] 44. Ge Y, Zadeh M, Mohamadzadeh M (2022) Vitamin B12 Regulates the Transcriptional, Metabolic, and Epigenetic Programing in Human Ileal Epithelial Cells. Nutrients. 10.3390/nu14142825 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 45. Su É, Villard C, Manneville JB (2023) Mitochondria: At the crossroads between mechanobiology and cell metabolism. Biol Cell 115(9):e2300010. 10.1111/boc.202300010 [ DOI ] [ PubMed ] [ Google Scholar ] 46. Caponi S, Mattana S, Ricci M et al (2016) Raman micro-spectroscopy study of living SH-SY5Y cells adhering on different substrates. Biophys Chem 208:48–53. 10.1016/J.BPC.2015.07.009 [ DOI ] [ PubMed ] [ Google Scholar ] 47. Hislop EW, Tipping WJ, Faulds K, Graham D (2022) Label-free imaging of lipid droplets in prostate cells using stimulated raman scattering microscopy and multivariate analysis. Anal Chem 94:8899–8908. 10.1021/acs.analchem.2c00236 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 48. Movasaghi Z, Rehman S, Rehman IU (2007) Raman spectroscopy of biological tissues. Appl Spectrosc Rev 42:493–541 [ Google Scholar ] 49. Pezzotti G, Adachi T, Imamura H et al (2023) In Situ Raman Study of Neurodegenerated Human Neuroblastoma Cells Exposed to Outer-Membrane Vesicles Isolated from Porphyromonas gingivalis. Int J Mol Sci. 10.3390/ijms241713351 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 50. Huang H, Li G, He Y, Chen J, Yan J, Zhang Q, Li L, Cai X (2024) Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention. Front Immunol 15:1404441. 10.3389/fimmu.2024.1404441 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 51. Michel V, Yuan Z, Ramsubir S, Bakovic M (2006) Choline transport for phospholipid synthesis. Exp Biol Med (Maywood) 231(5):490–504. 10.1177/153537020623100503 [ DOI ] [ PubMed ] [ Google Scholar ] 52. Surai PF, Earle-Payne K, Kidd MT (2021) Taurine as a natural antioxidant: from direct antioxidant effects to protective action in various toxicological models. Antioxidants 10(12):1876. 10.3390/antiox10121876 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 53. Pacia MZ, Majzner K, Czamara K et al (2020) Estimation of the content of lipids composing endothelial lipid droplets based on raman imaging. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1865:158758. 10.1016/J.BBALIP.2020.158758 [ DOI ] [ PubMed ] [ Google Scholar ] 54. Jové M, Mota-Martorell N, Obis È et al (2023) Lipid adaptations against oxidative challenge in the healthy adult human brain. Antioxidants. 10.3390/antiox12010177 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 55. Smolič T, Zorec R, Vardjan N (2022) Pathophysiology of lipid droplets in neuroglia. Antioxidants 11(1):22. 10.3390/antiox11010022 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 56. Danielli M, Perne L, Jarc Jovičić E, Petan T (2023) Lipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death. Front Cell Dev Biol 11:1104725. 10.3389/fcell.2023.1104725 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 57. Schaffner A, Li X, Gomez-Llorente Y et al (2019) Vitamin B 12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection. Cell Res 29:313–329. 10.1038/s41422-019-0153-8 [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article. Supplementary Materials ESM 1 (5.3MB, docx) (DOCX 5.28 MB) ESM 2 (807.4KB, pdf) (DOCX 807 KB) Data Availability Statement The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information files. Should any raw data files be needed in another format they are available from the corresponding author upon reasonable request. Articles from Molecular Neurobiology are provided here courtesy of Springer ACTIONS View on publisher site PDF (10.3 MB) Cite Collections Permalink PERMALINK Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Add to Collections Create a new collection Add to an existing collection Name your collection * Choose a collection Unable to load your collection due to an error Please try again Add Cancel Follow NCBI NCBI on X (formerly known as Twitter) NCBI on Facebook NCBI on LinkedIn NCBI on GitHub NCBI RSS feed Connect with NLM NLM on X (formerly known as Twitter) NLM on Facebook NLM on YouTube National Library of Medicine 8600 Rockville Pike Bethesda, MD 20894 Web Policies FOIA HHS Vulnerability Disclosure Help Accessibility Careers NLM NIH HHS USA.gov Back to Top

Record · ID 30511 · SHA-256 d464cd9cd07090d9
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.